Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
Sign in with Google
ENTITY
Soligenix (SNGX US)
Watchlist
13
Analysis
Health Care
•
United States
Soligenix, Inc. develops therapeutics and vaccines. The Company researches treatments for gastrointestinal Graft-versus-Host disease and cancer, and develops vaccines for military and civilian applications.
more
Watchlist
Filings
Presentations
Events
Earnings/Op Data
New
Refresh
Exchange Announcement •
05 May 2025 20:11
Annual Report to Security Holders (Form ARS | Period ending 2024-12-31)
Attachment
Exchange Announcement •
28 Mar 2025 20:05
Current Report (Form 8-K | Period ending 2025-03-25)
Attachment
Exchange Announcement •
21 Mar 2025 20:05
Annual Report (Form 10-K | Period ending 2024-12-31)
Attachment
Exchange Announcement •
08 Nov 2024 21:14
424B3 | Prospectus
Attachment
Exchange Announcement •
08 Nov 2024 21:12
424B3 | Prospectus
Attachment
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.53.3
x